The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
2.
Six breast texture patterns linked to higher risk of invasive cancer
3.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
4.
Scientists develop scans that light up aggressive cancer tumors for better treatment
5.
Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.
1.
Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment
2.
Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology
3.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
4.
Exploring the Unseen: Carcinoid Syndrome and its Impact on Quality of Life
5.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation